Global Liquid Embolic Device Market Growth 2023-2029

Global Liquid Embolic Device Market Growth 2023-2029

Liquid Embolic Device is a premixed, radiopaque, injectable embolic fluid designed for preoperative embolization of cerebral arteriovenous malformations (bAVMs).

LPI (LP Information)' newest research report, the “Liquid Embolic Device Industry Forecast” looks at past sales and reviews total world Liquid Embolic Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Liquid Embolic Device sales for 2023 through 2029. With Liquid Embolic Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Embolic Device industry.

This Insight Report provides a comprehensive analysis of the global Liquid Embolic Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liquid Embolic Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Liquid Embolic Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Embolic Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Embolic Device.

The global Liquid Embolic Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Liquid Embolic Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Liquid Embolic Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Liquid Embolic Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Liquid Embolic Device players cover Meril Life Sciences, Medtronic, Johnson and Johnson, MicroVention, Terumo Corporation, Balt and Saikesaisi Biological Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Embolic Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Liquid Embolic Vials
Liquid Embolic Prefilled Injectables

Segmentation by application
Brain Arteriovenous Malformation
Brain Aneurysm
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Meril Life Sciences
Medtronic
Johnson and Johnson
MicroVention
Terumo Corporation
Balt
Saikesaisi Biological Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liquid Embolic Device market?

What factors are driving Liquid Embolic Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Liquid Embolic Device market opportunities vary by end market size?

How does Liquid Embolic Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.